Discover and read the best of Twitter Threads about #ncyt
Most recents (24)
Fact check:
#Novacyt Exsig underwent Clinical & NHS validation
👇 Wrong:
"So in essence if you look you will not find a document (that I have ever seen) saying Exsig formally passed its in service trial in relation to the contract whereas you will find one for Promate"
#ALNOV
#Novacyt Exsig underwent Clinical & NHS validation
👇 Wrong:
"So in essence if you look you will not find a document (that I have ever seen) saying Exsig formally passed its in service trial in relation to the contract whereas you will find one for Promate"
#ALNOV
For supposed researched person, he's lazy. His thesis called out #Novacyt's 3rd party manufacturing for lowering margins
#ALNOV "invests in infrastructure to bring previously outsourced work in-house & to drive further automation, leading to improved margins & process controls"
#ALNOV "invests in infrastructure to bring previously outsourced work in-house & to drive further automation, leading to improved margins & process controls"
@UnrollHelper unroll
#ncyt #alnov #novacyt
That's nice. PROmate, as part of the national microbiology framework has it's own contract.
The £4m amount until next Year has been announced by @NovacytGroup a few weeks ago. But without any minimal amount secured as stated.
1/4
That's nice. PROmate, as part of the national microbiology framework has it's own contract.
The £4m amount until next Year has been announced by @NovacytGroup a few weeks ago. But without any minimal amount secured as stated.
1/4
#ncyt #alnov #novacyt
Now we have the contract in front of us.
"By execution of the contract, DHSC shall submit to the supplier a purchase order for the sum of xxxxx"
Interesting 🧐
2/4
Now we have the contract in front of us.
"By execution of the contract, DHSC shall submit to the supplier a purchase order for the sum of xxxxx"
Interesting 🧐
2/4
#ncyt #alnov #novacyt
Our relation with DHSC is far from over.
Monthly meetings to review several points.
Thanks to Steve Gibson, CFO, for signing this contract on behlaf of @NovacytGroup 🧐
3/4
Our relation with DHSC is far from over.
Monthly meetings to review several points.
Thanks to Steve Gibson, CFO, for signing this contract on behlaf of @NovacytGroup 🧐
3/4
2020 Figure's:
🇬🇧 70% sales NHS/DHSC
👨💼 18% via Distributors (UK & International)
🔬 12% Private Lab sales
#Novacyt #ALNOV #NCYT
🇬🇧 70% sales NHS/DHSC
👨💼 18% via Distributors (UK & International)
🔬 12% Private Lab sales
#Novacyt #ALNOV #NCYT
#Novacyt's COVID-19 tests received UKAS Medical Accreditation for use within 4 UK private labs in past month
✅ The Scientists Laboratory Ltd (10k daily capacity)
✅ Epistem Ltd
✅ MDNA Life Sciences Ltd
Courtesy of @BlackbirdInvest
#ALNOV #NCYT
✅ The Scientists Laboratory Ltd (10k daily capacity)
✅ Epistem Ltd
✅ MDNA Life Sciences Ltd
Courtesy of @BlackbirdInvest
#ALNOV #NCYT
Wren Healthcare received UKAS Accreditation for use of #Novacyt's Point of Care solution
Q16/32's with ProMATE, no bio hazard safety cabinet required
At least 9 Versalabs have been supplied with approx 900 daily capacity each #ALNOV #NCYT
Thank you @Larry64450205
Q16/32's with ProMATE, no bio hazard safety cabinet required
At least 9 Versalabs have been supplied with approx 900 daily capacity each #ALNOV #NCYT
Thank you @Larry64450205
MDNA & Newcastle airport 👇
While we await Q&A answers from & AGM agenda next week from @NovacytGroup here are some of the slides & video
Diagnostics set to boom 💥
#novacyt #ALNOV #NCYT building blocks in place for sustained growth
Diagnostics set to boom 💥
#novacyt #ALNOV #NCYT building blocks in place for sustained growth
#ncyt #alnov #novacyt
A little mixed thread.
Our R&D, the bioinformatic reports, SNPsig, PROmate, Versalab, DHSC, takeovers, the RNSs, wierd stuff, whats next, some risks, etc
1/20
A little mixed thread.
Our R&D, the bioinformatic reports, SNPsig, PROmate, Versalab, DHSC, takeovers, the RNSs, wierd stuff, whats next, some risks, etc
1/20
Waiting for AF LFT.
1m tests/week to start.
Shouldnt be long to wait, as theyre already looking for tenders for it. (See UN notice of interest)
For home use and professionnals. Very important. It opens many markets !
2/n
1m tests/week to start.
Shouldnt be long to wait, as theyre already looking for tenders for it. (See UN notice of interest)
For home use and professionnals. Very important. It opens many markets !
2/n
Why os the AG LFT not far away :
3/n
3/n
Novacyt has over 550+ tests.
So why haven't they been doing billions in revenue like their peers, and why are we expecting them to go mid cap like other diagnostics companies, now.
What's changed and why have investors been backing sustainable mid cap revenues?
#NCYT #ALNOV
So why haven't they been doing billions in revenue like their peers, and why are we expecting them to go mid cap like other diagnostics companies, now.
What's changed and why have investors been backing sustainable mid cap revenues?
#NCYT #ALNOV
When Novacyt acquired PrimerDesign in 2016, it was for their portfolio of tests and the talent within that team.
However those tests were research use only (RUO), and PrimerDesign themselves were not structured as a business that could sell into the clinical use market.
However those tests were research use only (RUO), and PrimerDesign themselves were not structured as a business that could sell into the clinical use market.
You have seen how much PCR tests cost. But you have also seen the accuracy needed and competition in that market. That competition exists for good reason - it's worth billions and has a 17.5% CAGR from 2020 to 2027.
Extremely bullish by SourceBio this morning.
Novacyt is always extremely conservative with market communications, though they're at two different stages. Novacyt is making mid cap money, but talking like an uncertain micro cap in RNS. Hence the chaos.
But..
#NCYT #ALNOV
Novacyt is always extremely conservative with market communications, though they're at two different stages. Novacyt is making mid cap money, but talking like an uncertain micro cap in RNS. Hence the chaos.
But..
#NCYT #ALNOV
If you look at non-market facing communications from @NovacytGroup at the moment. They're extremely bullish and confident about who they are and what they're doing.
Led the way on swine flu, covid and the horse meat scandal. Strong USPs.
Led the way on swine flu, covid and the horse meat scandal. Strong USPs.
Sales director role with heady focus on NHS sales. Many roles are NHS facing. So many people are confused over the procurement dispute. That's just one contract, and just one part within that contract. Not a breakdown in a relationship.
Bad spells are a show of character. You learn about people from it, on all sides of the equation.
Same with the brokers' reactions
SP Angel actually did the decent thing and held back from putting out a target until Mullis has had a bit more time to update them 👍
#NCYT #ALNOV
Same with the brokers' reactions
SP Angel actually did the decent thing and held back from putting out a target until Mullis has had a bit more time to update them 👍
#NCYT #ALNOV
Numis taking a moderate view, which although ridiculous around £5.70 for a company like this - they are starved of info on the next product and revenue streams, so can't fault them too strongly until sustained revenues are made official.
ODDO though.
Almost a parody of a dodgy brokerage, complete opportunists. They will have a clue a news flow period is coming up soon. Mullis has made that much clear - new tech and contracts in process for covid, and a longer sustained business plan.
Almost a parody of a dodgy brokerage, complete opportunists. They will have a clue a news flow period is coming up soon. Mullis has made that much clear - new tech and contracts in process for covid, and a longer sustained business plan.
Some great discussion and writing going around today. Hate to repeat a tweet but Friday really has made investors and potential investors take a step back and put #NCYT under the microscope.
Not everyone posts on main feed though.
Copying this from @duncanhallas..
Not everyone posts on main feed though.
Copying this from @duncanhallas..
Because it mirrors my feelings strongly about M&A right now. Some food for thought.
Duncan: "The more I think about it the more I don’t want NCYT to make a small bolt on acquisition at a very high premiums.
Duncan: "The more I think about it the more I don’t want NCYT to make a small bolt on acquisition at a very high premiums.
Interestingly the value we present to a future buyer based on our cash + incoming revenue + IP & operations is genuinely interesting. Remember CFOs are the ones that approve acquisitions.
Not a huge horse racing fan, but Rachel's amazing.
Her jersey, not so much.
Makes you realise though...
#NCYT #ALNOV #NVYTF
Her jersey, not so much.
Makes you realise though...
#NCYT #ALNOV #NVYTF
That all the main players have an advertising budget. I notice it because of the website. But Roche, Thermo, Qiagen etc are always there in my face. Constant ad spend, even on low volume blogs..
Smaller players, SourceBio etc.. all advertising.
So that's it. We can all move on now from the DHSC albatross around Novacyt's neck.
People selling off, shorts and MMs sticking the knife in.
But after that settles, we've actually got some good material in this RNS.
#NCYT #ALNOV #NVYTF
People selling off, shorts and MMs sticking the knife in.
But after that settles, we've actually got some good material in this RNS.
#NCYT #ALNOV #NVYTF
We have multiple COVID-19 LFTs coming.
Now confirmed by RNS so we will have a complete revenue stream for COVID-19 that only large caps like Roche have managed to output.
We actually will have a wider range than some large caps ie. Thermo & Perkin Elmer.
Very impressive.
Now confirmed by RNS so we will have a complete revenue stream for COVID-19 that only large caps like Roche have managed to output.
We actually will have a wider range than some large caps ie. Thermo & Perkin Elmer.
Very impressive.
We've done £30 to £40mill in Q1 2021 from private testing sales and have yet to launch several new products, including LFTs which are currently en-vogue.
Novacyt's team is expanding and pushing into new territories so 2021 revenues without DHSC are still mid cap level.
Novacyt's team is expanding and pushing into new territories so 2021 revenues without DHSC are still mid cap level.
#Novacyt more than COVID-19 🔬
🔎 550 non COVID range
. Human pathogen
. Veterinary
. Food, water & agriculture
. Bio threats
. Genotyping
Find out in April how #NCYT will leveraging it's role within 🇬🇧 diagnostics infrastructure
#ALNOV #Primerdesign
🔎 550 non COVID range
. Human pathogen
. Veterinary
. Food, water & agriculture
. Bio threats
. Genotyping
Find out in April how #NCYT will leveraging it's role within 🇬🇧 diagnostics infrastructure
#ALNOV #Primerdesign
#Novacyt's Genesig tests are designed to run on the q16 & larger q32 which is one of the fastest qPCR instruments in the world
I'm looking forward to seeing ProMATE being adapted to further simplify #NCYT testing base
I'm looking forward to seeing ProMATE being adapted to further simplify #NCYT testing base
#Novacyt have a Massive range of Respiratory Infection detection kits
& as demonstrated by COVID they are fast to react to new threats
& now UK has the tools & political will to test
#Novacyt #ALNOV #NCYT #Primerdesign
& as demonstrated by COVID they are fast to react to new threats
& now UK has the tools & political will to test
#Novacyt #ALNOV #NCYT #Primerdesign
Some PCR investor stress caused by reissue of LFT Tender
It's value was cut by 2/3rd's
£8b down from £20b
Bids submitted by 7th April
Add on bid evaluation period
& 30 days contact standstill / freeze period
#Novacyt #Microgen compete for both
bidstats.uk/tenders/2020/W…
It's value was cut by 2/3rd's
£8b down from £20b
Bids submitted by 7th April
Add on bid evaluation period
& 30 days contact standstill / freeze period
#Novacyt #Microgen compete for both
bidstats.uk/tenders/2020/W…
Is #Novacyt taking off 🛫?
Major flex by Novacyt today in response to ridiculous market conditions.
Decentralised testing flex.
Centralised testing flex.
LFT flex.
Validations flex.
Non-covid roadmap in Q2 will get the hype train moving shortly too.
#NCYT #ALNOV #NVYTF
londonstockexchange.com/news-article/N…
Decentralised testing flex.
Centralised testing flex.
LFT flex.
Validations flex.
Non-covid roadmap in Q2 will get the hype train moving shortly too.
#NCYT #ALNOV #NVYTF
londonstockexchange.com/news-article/N…
As always with a Novacyt infodump it takes weeks for the gravity of it to settle. All this tech will be realised in 2021+ in terms of revenues and growth. But it's all in there.
Initial thoughts?
Initial thoughts?
LFT modification to 'extend the revenue horizon for COVID-19'.
Many antibody LFTs on market simply haven't been selling. Uptake isn't there, especially in the UK. The requirements for these have changed, and the major rollout won't be until we have greater vax numbers.
Many antibody LFTs on market simply haven't been selling. Uptake isn't there, especially in the UK. The requirements for these have changed, and the major rollout won't be until we have greater vax numbers.
sent another reminder to Eurobio-Scientific (#ALERS) about my questions about the PCR test.
I received an answer this time:
"It is company policy not to communicate with specific investors in order to maintain equal access to information."
#NCYT #ALBIO #ALNOV
1/9
I received an answer this time:
"It is company policy not to communicate with specific investors in order to maintain equal access to information."
#NCYT #ALBIO #ALNOV
1/9
"I cannot answer your quite detailed questions."
Uhm, I'm only asking about the products, not about sensitive financial information.
Why not disclose this information?
2/9
Uhm, I'm only asking about the products, not about sensitive financial information.
Why not disclose this information?
2/9
I received the official Package Insert fur Flucosyn though.
Eurobio-Scientific is the biggest supplier of France and also a big exporter of PCR tests.
What did I find?
3/9
Eurobio-Scientific is the biggest supplier of France and also a big exporter of PCR tests.
What did I find?
3/9
I have serious doubts about the reliability of the PCR tests, which have a huge impact on society.
I am not a microbiologist but I was invested in PCR-testing companies and I found major red flags.
A thread.
#NCYT #ALERS #ALBIO
1/
I am not a microbiologist but I was invested in PCR-testing companies and I found major red flags.
A thread.
#NCYT #ALERS #ALBIO
1/
PCR-tests have created enormous wealth for pre-pandemic shareholders of PCR-testing companies.
For example, Novacyt, one of the first to deliver PCR tests in Europe, was trading at just 8 cents in November 2019. Now trading around 9 euros.
2/
For example, Novacyt, one of the first to deliver PCR tests in Europe, was trading at just 8 cents in November 2019. Now trading around 9 euros.
2/
PCR Tests have a huge influence on life. The tests are being used regularly for screening of doctors, nurses and travelers for example. Besides, the tests are being used for mass-testing the population.
Totalitarian Government policy is also justified by PCR positive cases.
3/
Totalitarian Government policy is also justified by PCR positive cases.
3/
BCG analyzed 🔬 🇺🇸, 🇫🇷 , 🇩🇪 , 🇮🇹, 🇪🇸 Outlook
Testing's likely to follow similar trajectories
Peak COVID demand occurring in the seasonally affected first quarters of 2021 & 2022
#Novacyt #ALNOV #NCYT
bcg.com/en-in/publicat…
Testing's likely to follow similar trajectories
Peak COVID demand occurring in the seasonally affected first quarters of 2021 & 2022
#Novacyt #ALNOV #NCYT
bcg.com/en-in/publicat…
Don't you wonder sometimes
About genes and vision?
#Novacyt #ALNOV #NCYT
“Our SNPsig assays are the same high level of accuracy as our PCR SARS-CoV-2 portfolio,” Mullis said. More variants will be added as they are identified.
About genes and vision?
#Novacyt #ALNOV #NCYT
“Our SNPsig assays are the same high level of accuracy as our PCR SARS-CoV-2 portfolio,” Mullis said. More variants will be added as they are identified.
“primary challenge for COVID-19 diagnostics companies is ensuring their products continue to accurately test for the virus, regardless of the variant, and to innovate at the challenging pace required to remain clinically relevant"
Graham Mullis #Novacyt
bioworld.com/articles/50347…
Graham Mullis #Novacyt
bioworld.com/articles/50347…
Prof Sharon Peacock Cambridge Uni, her work sequencing variants may be required for at least 10 yrs
bbc.co.uk/news/uk-560199…
#Novacyt #ALNOV #NCYT
bbc.co.uk/news/uk-560199…
#Novacyt #ALNOV #NCYT
UK micro > small cap 🔬 snap shot
#Novacyt
Sales - £277m
Cash - £92m
COVID prods on sale - 10+
Market Cap - £565m
#Abingdon, #BBI, #Omega, #Avacta, #GeneDrive (#GDR) & #Yourgene
Sales - £28m > £30m (Yourgene £18>£20m)
Cash - 🤔
COVID prods on sale - 3🤔
Market Cap - £761m
#Novacyt
Sales - £277m
Cash - £92m
COVID prods on sale - 10+
Market Cap - £565m
#Abingdon, #BBI, #Omega, #Avacta, #GeneDrive (#GDR) & #Yourgene
Sales - £28m > £30m (Yourgene £18>£20m)
Cash - 🤔
COVID prods on sale - 3🤔
Market Cap - £761m
There's a margin of error to account for BBI accounts which aren't public, awaiting GeneDrive which reports 31/03, Avacta account were published 23/01 last yr.
Say £5m tops. Small fry when you consider imbalance of collective market capitalisations.
Say £5m tops. Small fry when you consider imbalance of collective market capitalisations.
#ncyt #alnov #novacyt
SP Angel published a New note on #ncyt
You Can Access the full document here :
novacyt.com/wp-content/upl…
The target Price is 1433p, but there are many interesting things in this document.
Thread ⤵️
1/15
SP Angel published a New note on #ncyt
You Can Access the full document here :
novacyt.com/wp-content/upl…
The target Price is 1433p, but there are many interesting things in this document.
Thread ⤵️
1/15
First, the FY2020 results are better than in the last forecast.
Actual vs previous forecast
Revenue 311m vs 287m
Cash 101m vs 79m
The cash accumulated will allow them to develop themselves into a "high margin clinical diagnostics" sector.
2/n
Actual vs previous forecast
Revenue 311m vs 287m
Cash 101m vs 79m
The cash accumulated will allow them to develop themselves into a "high margin clinical diagnostics" sector.
2/n
Revenues and forecast.
Things are really important here.
We Can see the revenues decrease until 2023 on this forecast.
But look at the cash accumulation. This will not sit in the bank and wait !
So, when they use this cash for aquisitions for ex.,
3/n
Things are really important here.
We Can see the revenues decrease until 2023 on this forecast.
But look at the cash accumulation. This will not sit in the bank and wait !
So, when they use this cash for aquisitions for ex.,
3/n
Novacyt.
Coming clean.
There's a deceit that goes around the social media game when it comes to pushing stocks and many of us are admittedly a part of that.
#NCYT #ALNOV #NVYTF
Coming clean.
There's a deceit that goes around the social media game when it comes to pushing stocks and many of us are admittedly a part of that.
#NCYT #ALNOV #NVYTF
The 1st deceit is the lack of emphasis on how extremely volatile the market is for any particular stock on AIM - it only really gets discussed after the fact, like today for example.
30% and 40% swings in a week is extreme.
30% and 40% swings in a week is extreme.
You're better off trading that.
We all know it.
We all know it.
#ncyt #alnov
#novacyt has a great capacity in identifying the needs of the market.
Many tests developped this year respond to precise needs
And there are many more to Come this year
- History
- promate & its future
- rt-lamp
- LFT
- sequencing and variants
Thread 1/17 ⤵️
#novacyt has a great capacity in identifying the needs of the market.
Many tests developped this year respond to precise needs
And there are many more to Come this year
- History
- promate & its future
- rt-lamp
- LFT
- sequencing and variants
Thread 1/17 ⤵️
Little History.
- covid-HT was specificly developped for the AZN lighthouse lab in Cambridge
- Winterplex was one of the first of his kind, developped to answer the needs of NHS
2/n
- covid-HT was specificly developped for the AZN lighthouse lab in Cambridge
- Winterplex was one of the first of his kind, developped to answer the needs of NHS
2/n
- exsig direct direct to symplify the workflow of the PCR
- mink strain test : theyre the first ones, again, for this test, who could have had a sognificant importance if this strain had spread
3/n
- mink strain test : theyre the first ones, again, for this test, who could have had a sognificant importance if this strain had spread
3/n
